查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1223360

近距離放射治療的全球市場:各產品類型，各給藥類型，各用途，各終端用戶地區展望，競爭策略，市場區隔預測(～2032年)

Brachytherapy Market Size-By Product, By Dosage Type, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球近距離放射治療的市場規模，預計到2032年以7.33％的CAGR成長，達到18億4,000萬美元。加速乳房部分照射(APBI)的近距離放射治療的利用擴大，乳癌的發生率增加，預計促進市場成長。

本報告提供全球近距離放射治療市場相關調查分析，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
    • 二次資料
    • 一次資料
    • SPER內部資料庫
    • KOL的洞察
  • 市場規模的估計
    • Top-Down(由上而下)和Bottom-Up(由下而上)的方法
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球近距離放射治療市場的COVID-19影響

第5章 市場變數與展望

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術性形勢
    • 環境的形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 競爭情形

  • 全球近距離放射治療的製造地的分佈，銷售地區，產品類型
  • 全球近距離放射治療市場合併和收購，夥伴關係，產品銷售，及合作

第7章 全球近距離放射治療市場(100萬美元)(2019年～2032年):各產品

  • 施用器和後荷機
  • 電子近距離放射治療
  • 種子

第8章 全球近距離放射治療市場(100萬美元)(2019年～2032年):各給藥類型

  • 高線量率(HDR)
  • 低劑量率(LDR)

第9章 全球近距離放射治療市場(100萬美元)(2019年～2032年):各用途

  • 乳癌
  • 婦產科癌症
  • 前列腺癌症
  • 其他

第10章 全球近距離放射治療市場(100萬美元)(2019年～2032年):各終端用戶

  • 醫院
  • 專門診所
  • 其他

第11章 全球近距離放射治療市場(100萬美元)(2019年～2032年):各地區

  • 全球近距離放射治療的市場規模與市場佔有率(2019年～2025年):各地區
  • 全球近距離放射治療的市場規模與市場佔有率(2026年～2032年):各地區
  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他的歐洲
  • 中東和非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東
  • 北美
    • 加拿大
    • 墨西哥
    • 美國
  • 南美
    • 阿根廷
    • 巴西
    • 其他的南美

第12章 企業簡介

  • Argon Medical Devices
  • Becton
  • Best Vascular, Inc
  • Carl Zeiss Meditec AG
  • CIVCO MEDICAL SOLUTIONS
  • Dickinson and Company
  • Eckert & Ziegler BEBIG S.A
  • Elekta AB
  • iCAD Inc
  • Isoray Inc
  • Panacea Medical Technology Pvt. Ltd.
  • RadiaDyne
  • SUN NUCLEAR CORPORATION
  • Theragenics Corporation
  • VARIAN MEDICAL SYSTEMS, INC.

第13章 簡稱一覽

第14章 參照鏈接

第15章 結論

第16章 調查範圍

簡介目錄
Product Code: HLCA2312

Global Brachytherapy Market Overview

According to SPER Market Research, the Global Brachytherapy Market is estimated to reach USD 1.84 billion by 2032 with a CAGR of 7.33%.

Brachytherapy equipment is recommended over other radiation therapy equipment for cancer therapy because patients treated with this equipment have a low chance of experiencing a future relapse. Image Guided Brachytherapy (IGBT) and Pulse Dose Rate are two other contemporary brachytherapy techniques (PDR). Brachytherapy is currently enabled by programming agreements that enable the providers of medical services to legally provide and schedule brachytherapy for patients. In the previous years, the prostate cancer market was anticipated to dominate and account for the largest income share. Brachytherapy is a viable treatment option for all individuals with confined prostate cancer development, both when used alone and in conjunction with outer bar radiation therapy. The category is being driven by the promising applications of brachytherapy in the treatment of prostate cancer. During the projection period, a significant CAGR is anticipated for the breast cancer brachytherapy application segment. One of the main factors propelling the development of this market is the growing usage of brachytherapy in Accelerated Partial Breast Irradiation (APBI). Additionally, the growing incidence of breast cancer is anticipated to fuel the growth of this market.

Impact of COVID-19 on the Global Brachytherapy Market

Global healthcare systems have been impacted by the COVID-19 epidemic, and the market for brachytherapy equipment has also been significantly impacted. According to last year study titled "The Impact of COVID-19 on Brachytherapy," Advances in radiation oncology allowed six patients with unfavourable intermediate- and high-risk diseases to elect to receive EBRT followed by a brachytherapy boost, and since elective surgeries had to be postponed within the system due to the pandemic, four patients were treated with brachytherapy instead. The majority of cancer patients were safely treated with just minimal treatment delays and disruptions, despite the difficulties the healthcare system experienced throughout the epidemic. Therefore, they were considerably impacted as a result of the restrictions imposed by COVID-19. However, the need for brachytherapy equipment is anticipated to increase due to the rise in cardiac procedures.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2032

Base year considered 2021

Forecast period 2022-2032

Segments covered By Product, By Dosage Type, By End User, By Application.

Regions covered Asia-Pacific, Europe, Middle East and Africa, North America, Latin America

Companies Covered Argon Medical Devices, Becton, Best Vascular, Carl Zeiss Meditec AG, CIVCO MEDICAL SOLUTIONS, Dickinson and Company, Eckert & Zieglet BEBIG A.G, Elekta AB, iCAD Inc, Isoray Inc, Panacea Medical Technology Pvt. Ltd., RadiaDyne, SUN NUCLEAR CORPORATION, Theragenics Corporation, VARIAN MEDICAL SYSTEMS, Inc.

Global Brachytherapy Market Segmentation:

By Product: Based on the Type, Global Brachytherapy Market is segmented as; (Applicators & Afterloaders, Electronic Brachytherapy, Seeds)

By Dosage: Based on the Dosage, Global Brachytherapy Market is segmented as;(High-Dose Rate (HDR)Brachytherapy, Low-Dose Rate (LDR)Brachytherapy)

By End User: Based on the End User, Global Brachytherapy Market is segmented as; (Hospitals, Specialty Clinics, Others)

By Application: Based on the Application, Global Brachytherapy Market is segmented as; (Breast Cancer, Gynecological Cancer, Prostate Cancer, Others)

By Region: The regions of Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa make up the worldwide market. Due to the significant presence of major international players and the widespread use of cutting-edge brachytherapy technologies by healthcare facilities in the region, North America is anticipated to dominate the market during the forecast period.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Brachytherapy Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Competitive Landscape

  • 6.1 Global Brachytherapy Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Brachytherapy Market

7. Global Brachytherapy Market, By Product, 2019-2032 (USD Million)

  • 7.1 Applicators & Afterloaders
  • 7.2 Electronic Brachytherapy
  • 7.3 Seeds

8. Global Brachytherapy Market, By Dosage Type, 2019-2032 (USD Million)

  • 8.1 High-Dose Rate (HDR)Brachytherapy
  • 8.2 Low-Dose Rate (LDR)Brachytherapy

9. Global Brachytherapy Market, By Application, 2019-2032 (USD Million)

  • 9.1 Breast Cancer
  • 9.2 Gynecological Cancer
  • 9.3 Prostate Cancer
  • 9.4 Others

10. Global Brachytherapy Market, By End-User, 2019-2032 (USD Million)

  • 10.1 Hospitals
  • 10.2 Specialty Clinics
  • 10.3 Others

11. Global Brachytherapy Market, By Region, 2019-2032 (USD Million)

  • 11.1 Global Brachytherapy Market Size and Market Share by Region (2019-2025)
  • 11.2 Global Brachytherapy Market Size and Market Share by Region (2026-2032)
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Europe
    • 11.4.1 France
    • 11.4.2 Germany
    • 11.4.3 Italy
    • 11.4.4 Spain
    • 11.4.5 United Kingdom
    • 11.4.6 Rest of Europe
  • 11.5 Middle East and Africa
    • 11.5.1 Kingdom of Saudi Arabia
    • 11.5.2 United Arab Emirates
    • 11.5.3 Rest of Middle East & Africa
  • 11.6 North America
    • 11.6.1 Canada
    • 11.6.2 Mexico
    • 11.6.3 United States
  • 11.7 Latin America
    • 11.7.1 Argentina
    • 11.7.2 Brazil
    • 11.7.3 Rest of Latin America

12.Company Profiles

  • 12.1 Argon Medical Devices
    • 12.1.1 Company details
    • 12.1.2 Financial outlook
    • 12.1.3 Product summary
    • 12.1.4 Recent developments
  • 12.2 Becton
    • 12.2.1 Company details
    • 12.2.2 Financial outlook
    • 12.2.3 Product summary
    • 12.2.4 Recent developments
  • 12.3 Best Vascular, Inc
    • 12.3.1 Company details
    • 12.3.2 Financial outlook
    • 12.3.3 Product summary
    • 12.3.4 Recent developments
  • 12.4 Carl Zeiss Meditec AG
    • 12.4.1 Company details
    • 12.4.2 Financial outlook
    • 12.4.3 Product summary
    • 12.4.4 Recent developments
  • 12.5 CIVCO MEDICAL SOLUTIONS
    • 12.5.1 Company details
    • 12.5.2 Financial outlook
    • 12.5.3 Product summary
    • 12.5.4 Recent developments
  • 12.6 Dickinson and Company
    • 12.6.1 Company details
    • 12.6.2 Financial outlook
    • 12.6.3 Product summary
    • 12.6.4 Recent developments
  • 12.7 Eckert & Ziegler BEBIG S.A
    • 12.7.1 Company details
    • 12.7.2 Financial outlook
    • 12.7.3 Product summary
    • 12.7.4 Recent developments
  • 12.8 Elekta AB.
    • 12.8.1 Company details
    • 12.8.2 Financial outlook
    • 12.8.3 Product summary
    • 12.8.4 Recent developments
  • 12.9 iCAD Inc
    • 12.9.1 Company details
    • 12.9.2 Financial outlook
    • 12.9.3 Product summary
    • 12.9.4 Recent developments
  • 12.10 Isoray Inc
    • 12.10.1 Company details
    • 12.10.2 Financial outlook
    • 12.10.3 Product summary
    • 12.10.4 Recent developments
  • 12.11 Panacea Medical Technology Pvt. Ltd.
    • 12.11.1 Company details
    • 12.11.2 Financial outlook
    • 12.11.3 Product summary
    • 12.11.4 Recent developments
  • 12.12 RadiaDyne
    • 12.12.1 Company details
    • 12.12.2 Financial outlook
    • 12.12.3 Product summary
    • 12.12.4 Recent developments
  • 12.13 SUN NUCLEAR CORPORATION
    • 12.13.1 Company details
    • 12.13.2 Financial outlook
    • 12.13.3 Product summary
    • 12.13.4 Recent developments
  • 12.14 Theragenics Corporation
    • 12.14.1 Company details
    • 12.14.2 Financial outlook
    • 12.14.3 Product summary
    • 12.14.4 Recent developments
  • 12.15 VARIAN MEDICAL SYSTEMS, INC.
    • 12.15.1 Company details
    • 12.15.2 Financial outlook
    • 12.15.3 Product summary
    • 12.15.4 Recent developments

13.List of Abbreviations

14.Reference Links

15.Conclusion

16.Research Scope